IN THE MEDIA
Cannara Biotech CFO Nicholas Sosiak: Unveiling Success Strategies and Future Plans
Cannara Biotech Inc CFO Nicholas Sosiak joined Steve Darling from Proactive to provided valuable insights into the company’s success in the cannabis industry.
Sosiak discussed the company’s strategic acquisitions, including the purchase of a 1 million square foot cannabis facility for $27 million, significantly below its initial cost. Cannara Biotech Inc. has also developed three in-house brands: Tribal, Nugs, and Orchid CBD, each catering to specific market niches. The company places a strong emphasis on consistency and quality to drive brand loyalty among consumers.
Cannara Biotech Q1 Results: Revenue, Net Income and Market Share Up, Quarter Also Marks Company’s First Export Sale
With the demand for high-quality, affordably priced cannabis growing in Canada, Cannara Biotech Inc.’s (LOVFF) investments seem to be paying off. The vertically integrated producer of premium-grade cannabis and derivative product offerings has used investment dollars to produce quality cannabis products and increase the number of growing zones. That has resulted in Montreal-based Cannara Biotech reporting record-setting revenue for its first quarter and forecast even more growth to come in 2024.
Cannara Biotech Market Share Gains Result In Record-Setting Fourth Quarter
Thanks in part to market share gains and increasing demand for high-quality cannabis at an affordable price in Canada, Cannara Biotech Inc., LOVFF, the vertically integrated producer of premium-grade cannabis and derivative product offerings, reported record growth in revenue and net income for its fourth quarter of 2023.
Cannara Biotech, la floraison du cannabis légal
A retrospective on the cannabis market after 5 years of legalization.
“Le Soleil”, a 1896 Quebec-based paper, brings us an amazing article glorifying Cannara’s success. Interesting quotes from key organization players including the CFO, the CEO, the CTO and the General Manager.
Derriere le buzz!
A retrospective on the cannabis market after 5 years of legalization.
Extremely positive article about Cannara Biotech Inc. in the French Canadian newspaper “La Presse”.
OCS Trailblazers!
OCS hosted an interview with a few key players in the Canadian Cannabis industry. Our CFO was selected. Check the whole video here!
Weedcrawler Podcast!
PODCAST: Hosted by Alex, the founder/owner of Weedcrawler and BestBangforYourBud.
Extremely interesting podcast. Cannara helped Weedcrawler start up and they have helped us tremendously about market data over the years.
HIGHERORBIT | Now THAT’S Dank!
PODCAST: Hosts Charlie and Sean Kady are excited to welcome entrepreneur and chartered professional accountant Nicholas Sosiak, also known as Niko Dank, to the show.
Cannara Biotech Inc. To Participate At Canaccord Genuity’s 7th Annual Global Cannabis Conference!
Cannara announced its upcoming participation at Canaccord Genuity’s 7th annual global cannabis conference.
PBA May 5à7 Investors Cocktail with Cannara Biotech, TSXV: LOVE and NIO STRATEGIC METALS, TSX-V: NIO!
Video Interview with our CFO Nick Sosiak.
TMX ONSITE: CANNARA BIOTECH INC.
March 1, 2023 | Author: TMX Group
TMX is a Canadian company that provides customized information and workflow solutions to clients in the financial and energy industries. Their services include real-time market data, analytics, and trading solutions.
Ontario Cannabis Fieldnotes: Cannara Biotech Blends Business with Pleasure
Montreal-based Licensed Producer Cannara Biotech began with a bang in early 2018. By July of that year, they had secured a 625,000-square-foot facility in southern Quebec.
Branding and genetics: Q&A with Nick Sosiak
Nick Sosiak, or Niko Dank, CFO and Senior Product Developer at Cannara Biotech, shares an in-depth look at the Quebec limited partnership’s operations and its role in forming three brands backed by the art of cannabis breeding .
ROCKWOOL – names one of the most sustainable companies in the world
Our CFO shares his expertise on the crucial topic of sustainability and its immense benefits within the booming cannabis industry.
SpotlightMedia – Cannara Podcast (With Nick Sosiak)
Listen to the full podcast on Spotify. Nick elaborates on the Cannara Brand as a whole and touches on a multitude of subjects.
Top 25 Healthcare Technology Leaders of Montreal for 2022 – Where did we rank?
Our CFO, Nicholas Sosiak, has ranked #6 of the top 25 Healthcare Technology Leaders from Montreal.
Our CFO, Nicholas Sosiak talks about the KIND Winter Fair that happened in Toronto’s “Rendez-View” on the 7th & 8th of December 2022. Live from CityTV!
Disciplined Stoners – Podcast full Interview.
In this podcast from the “Disciplined Stoners”, Nicholas Sosiak & KIND organizer Nicole Wolfe discuss the KIND Winter Fair event.
In this article from the Cannabis Growing Magazine “Grow Opportunity“, Nicholas Sosiak discusses the various aspects of strategic partnerships between LPs and people who breed Cannabis.
Cannara Biotech: Canadian Cannabis Grow with Nicholas Sosiak
In this episode, Nick Morin interviews Nicholas Sosiak from Cannara BioTech, we get to learn about the Canadian cannabis industry, his vision to grow great cannabis and more!
Our CFO Nicholas Sosiak on the Grodan Groshow podcast.
During the show, Nicholas details his journey into the cannabis industry, how Cannara came to be, his love of genetics, the joys and challenges of the Canadian cannabis industry, and what’s next for Cannara.
Cannara Biotech: A Deep Dive
Technical420 goes deep in financial analysis of Cannara
Investor webcast
Our CFO, Nicholas Sosiak, discuss key areas of Cannara’s business.
Listen to Nick Sosiak during a livestream and interview with Rod from POW Group.
You will be getting an update on Cannara’s recent financials and plans for the next few quarters, new products and partnerships, and much more!
Cannara helps bring Exotic Mike’s famous buds to Canada.
Well-established Quebec cultivator enters into exclusive brand partnership with Exotic Genetix.
This Is Why Cannara Biotech Is An Execution Story That Is Flying Under The Radar
Read about why Cannara is one of the most misunderstood cannabis operators in North America.
OTCQB Podcast
Nicholas Sosiak joins OTCQB to share how the company crafts the brand and culture to build brand loyalty.
“This ‘sharing of knowledge’ is what makes our industry so awesome”
4/20 special series with Nicholas on insights on the cannabis industry’s developments and prospects.
Is there money to be made in Quebec if cannabis is legalized in the United States?
Discussion with journalist Emile Berube-Lupien on Canada’s place in the recent legislation.
Nick Sosiak on Interview Series from mycannabis
Nicholas takes us through his journey as CFO for Cannara Biotech as he shares insights into the critical success factors that any cannabis entrepreneur should fully grasp.
Nicholas Sosiak today on The Green Peak with Richard Zwicky on Cannabis Radio
Interview with The Green Peak discussing Cannara’s growth strategy and the viability of growing/cultivation in Canada.
Cannabinoid Project’s Podcast with Nick Sosiak
Topics Discussed:
- The current state of the second wave of Canadian LPs
- Shifting focus from cultivation to CPG
- Product formulation trends in Canada
- Canadian cannabis marketing restrictions
- Genetics to keep SKUs fresh and maintain sales volume
Our CFO at The Green Rush Podcast
Listen as they explore the unique Quebec market, Cannara’s business model, why flower remains king and how his team is building immense brand loyalty despite stringent marketing regulations.
Rising High: Exclusive talk with cannabis producer Cannara Biotech.
The piece highlights Q1 earnings, Cannara’s footprint in Quebec and how flower continues to steer the sales in the cannabis market.
Flower Still King Of US
“The market might be shifting to a “second wave” of cannabis cultivators who focus more on the craft side of growing than the large companies that control the bulk of the market.” said Nick Sosiak, Chief Financial Officer.
How Cannara Biotech is dominating the new wave of cannabis cultivation
Our CFO discusses the accelerated retail price compression of cannabis products.
POW Group Interviews Cannara CFO
Discussion about the new Valleyfield facility, market outlook, MD&A, regulations, financials and much more.